Jongwon Im
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
Papers in ⓘ
-
- Cancer Research and Treatments 4
-
- Anesthesia and Neurotoxicity Research 1
- Co-authors
- Tal Danino (4 shared papers)Jaeseung Hahn (3 shared papers)Nicholas Arpaia (3 shared papers)Fangda Li (3 shared papers)Tetsuhiro Harimoto (2 shared papers)Kam W. Leong (3 shared papers)Courtney Coker (2 shared papers)Candice R. Gurbatri (2 shared papers)
- Journals
- Nature (1 paper)Nature Chemical Biology (1 paper)Advanced Science (1 paper)Science (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- United StatesSouth KoreaPuerto Rico
In The Last Decade
Jongwon Im
6 papers receiving 465 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Biotechnology 243
- Drug Discovery 1
- Biomedical Engineering 233
- Immunology 73
- Oncology 81
Countries citing papers authored by Jongwon Im
This map shows the geographic impact of Jongwon Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jongwon Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jongwon Im more than expected).
Fields of papers citing papers by Jongwon Im
This network shows the impact of papers produced by Jongwon Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jongwon Im. The network helps show where Jongwon Im may publish in the future.
Co-authors
The 25 scholars most cited alongside Jongwon Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A programmable encapsulation system improves delivery of therapeutic bacteria in mice Hit paper breakdown → | 2022 | 171 |
| 2 | Probiotic-guided CAR-T cells for solid tumor targeting Hit paper breakdown → | 2023 | 146 |
| 3 | Probiotic neoantigen delivery vectors for precision cancer immunotherapy Hit paper breakdown → | 2024 | 70 |
| 4 | 2023 | 60 | |
| 5 | 2021 | 15 | |
| 6 | 2024 | 9 |
About Jongwon Im
Jongwon Im is a scholar working on Biotechnology, Developmental Neuroscience, Ecology, Genetics and Pediatrics, Perinatology and Child Health, having authored 6 papers that have together received 471 indexed citations. Recurring topics across this work include Cancer Research and Treatments (4 papers), Bacteriophages and microbial interactions (3 papers), CAR-T cell therapy research (1 paper), Birth, Development, and Health (1 paper), Nanoplatforms for cancer theranostics (1 paper), Microbial Metabolic Engineering and Bioproduction (1 paper), Anesthesia and Neurotoxicity Research (1 paper) and Adipose Tissue and Metabolism (1 paper). The work is most often cited by research in Biotechnology (243 citations), Drug Discovery (1 citation), Biomedical Engineering (233 citations), Immunology (73 citations) and Oncology (81 citations). Jongwon Im has collaborated with scholars based in United States, South Korea and Puerto Rico. Frequent co-authors include Tal Danino, Jaeseung Hahn, Nicholas Arpaia, Fangda Li, Tetsuhiro Harimoto, Kam W. Leong, Courtney Coker, Candice R. Gurbatri, Rosa L. Vincent and Mathieu Rouanne. Their work appears in journals such as Nature, Nature Chemical Biology, Advanced Science, Science and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.